Hillrom Announces Planned Acquisition Of Bardy Diagnostics, Inc.

Bardy DiagnosticsAvery WilliamsJanuary 19, 20212021

Bardy Diagnostics® Announces Appointment of Kevin Hykes as President and Chief Executive Officer

Bardy DiagnosticsAvery WilliamsSeptember 9, 20202021

Bardy Diagnostics™ Announces Use of The Carnation Ambulatory Monitor Patch to Measure QT Segments in COVID-19 Patients Using Hydroxychloroquine

Bardy DiagnosticsAvery WilliamsMarch 25, 20202021

BardyDx Receives FDA 510(k) Clearance for 14-Day Carnation Ambulatory Monitor (CAM) Patch

Bardy Diagnostic announced it received 510(k) clearance from the FDA for the 14-Day version of the Carnation Ambulatory Monitor ("CAM™"), the industry's only P-wave centric™ ambulatory cardiac patch monitor and arrhythmia detection device.

Bardy DiagnosticsAvery WilliamsSeptember 10, 20192021

Bardy Diagnostics Selected as Winner of the MedTech Breakthrough Award For Best New Diagnostic Technology

Bardy Diagnostics, a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced that MedTech Breakthrough, an independent organization that recognizes the top companies and solutions in the global health and medical technology market, has recognized the Carnation Ambulatory Monitor (CAM™) with the "Best New Diagnostic Technology" award in the 2019 MedTech Breakthrough Awards program. Bardy Diagnostics earned the distinction for its innovative P-wave centric™ ambulatory cardiac patch monitoring and arrhythmia detection technology.